
NanoClear uses a proprietary process to alter the wettability of any arbitrary surface to create anti-fogging and anti-frost performance in both consumer and industrial applications.
Market:
Several inexpensive/temporary solutions have existed in the commercial marketplace for some time. These solutions involved sprays, wipes, or coatings. The major challenge with these existing solutions is their durability. NanoClear’s proprietary technology provides an inexpensive and permanent solution to fogging problems associated with many consumer wearables and in situations where frost formation is undesirable.
Technology:
NanoClear’s unique, patented process technology is not a coating. Rather, the textures are produced in the target material itself so that the material is inherently anti-fogging. This is achieved by leveraging the mature, high performance, and high throughput semiconductor processes that have been used to create increasingly more powerful computer chips for decades. Moreover, NanoClear’s approach is simple and has achieved an extremely high-level of performance without the need for expensive lithography or patterning steps.Advantages:
- Applicable to any arbitrary substrate
- Permanent solution
- Does not crack or delaminate
- No degradation in performance
Development Stage:
- Prototype
Patents Issued:
- Some key portions of NanoClear's proprietary technology were originally developed at JPL/Caltech by one of the founders. This technology is covered by multiple patents, both provisional and non-provisional, which are exclusively licensed to NanoClear.
Graduated in 2019
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- Millibatt
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne Particle Analysis
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio